Cargando…

Serum Level of Cytokeratin 18 (M65) as a Prognostic Marker of High Cardiovascular Disease Risk in Individuals with Non-Alcoholic Fatty Liver Disease

Alterations in apoptosis, as reflected by circulating Cytokeratin 18 (CK18), are involved in the progression of non-alcoholic fatty liver disease (NAFLD) to non-alcoholic steatohepatitis and atherogenesis. We aimed to explore the discriminant accuracy of Cytokeratin 18 (CK18, including M65 and M30 f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pagano, Sabrina, Bakker, Stephan J. L., Juillard, Catherine, Dullaart, Robin P. F., Vuilleumier, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377236/ https://www.ncbi.nlm.nih.gov/pubmed/37509164 http://dx.doi.org/10.3390/biom13071128

Ejemplares similares

Antibody against apolipoprotein-A1, non-alcoholic fatty liver disease and cardiovascular risk: a translational study
por: Pagano, Sabrina, et al.
Publicado: (2023)

Autoantibodies to Apolipoprotein A-1 as Independent Predictors of Cardiovascular Mortality in Renal Transplant Recipients
por: Anderson, Josephine L.C., et al.
Publicado: (2019)

Association of liver biomarkers and cytokeratin-18 in Nonalcoholic fatty liver disease patients
por: Altaf, Benash, et al.
Publicado: (2020)

Serum Cytokeratin 18 as a Metastatic and Therapeutic Marker for Extramammary Paget’s Disease
por: URANO-TAKAOKA, Mariko, et al.
Publicado: (2022)

Antibodies Against the C-Terminus of ApoA-1 Are Inversely Associated with Cholesterol Efflux Capacity and HDL Metabolism in Subjects with and without Type 2 Diabetes Mellitus
por: Dullaart, Robin P. F., et al.
Publicado: (2019)

Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis
por: Lee, Jenny, et al.
Publicado: (2020)

Elevated Serum Level of Cytokeratin 18 M65ED Is an Independent Indicator of Cardiometabolic Disorders
por: Qian, Lingling, et al.
Publicado: (2020)

Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization study
por: Kunutsor, Setor K., et al.
Publicado: (2019)

Higher Sodium Intake Assessed by 24 Hour Urinary Sodium Excretion Is Associated with Non-Alcoholic Fatty Liver Disease: The PREVEND Cohort Study
por: van den Berg, Eline H., et al.
Publicado: (2019)

Soluble Vascular Cell Adhesion Molecules May be Protective of Future Cardiovascular Disease Risk: Findings from the PREVEND Prospective Cohort Study
por: Kunutsor, Setor K., et al.
Publicado: (2017)

Impact of SARS-CoV2 infection on anti-apolipoprotein A-1 IgG response in inflammatory rheumatic diseases
por: Lamacchia, Celine, et al.
Publicado: (2023)

Prescription of statins in suspected non‐alcoholic fatty liver disease and high cardiovascular risk, a population‐based study
por: van den Berg, Eline H., et al.
Publicado: (2019)

Complementary Role of Fibroblast Growth Factor 21 and Cytokeratin 18 in Monitoring the Different Stages of Nonalcoholic Fatty Liver Disease
por: Wu, Guangyu, et al.
Publicado: (2017)

Auto-antibodies against apolipoprotein A-1 block cancer cells proliferation and induce apoptosis
por: Satta, Nathalie, et al.
Publicado: (2020)

Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Saeed, Ali, et al.
Publicado: (2017)

Stem Cell Markers (Cytokeratin 17 and Cytokeratin 19) in Scarring and Nonscarring Alopecia
por: El Sakka, Dalia, et al.
Publicado: (2016)

Cytokeratins 18 and 8 are poor prognostic markers in patients with squamous cell carcinoma of the oesophagus
por: Makino, T, et al.
Publicado: (2009)

Non-Alcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: Role of Circulating Branched-Chain Amino Acids
por: van den Berg, Eline H., et al.
Publicado: (2019)

Oxidative stress is associated with suspected non‐alcoholic fatty liver disease and all‐cause mortality in the general population
por: Damba, Turtushikh, et al.
Publicado: (2020)

Apolipoprotein A-II Influences Apolipoprotein E-Linked Cardiovascular Disease Risk in Women with High Levels of HDL Cholesterol and C-Reactive Protein
por: Corsetti, James P., et al.
Publicado: (2012)

Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease
por: Kosasih, Sumitro, et al.
Publicado: (2018)

Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients
por: Huang, Jee-Fu, et al.
Publicado: (2017)

Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty Liver
por: Del Ben, M., et al.
Publicado: (2014)

The Significance of Caspase-Cleaved Cytokeratin 18 in Pleural Effusion
por: Lee, Keu Sung, et al.
Publicado: (2014)

Serum Cytokeratin-18 Levels for Liver Fibrosis Prediction
por: Caviglia, Gian Paolo, et al.
Publicado: (2015)

Cytokeratin-18 in Diagnosis of HCC in Patients with Liver Cirrhosis
por: Ismail, Saber A, et al.
Publicado: (2017)

Serum Alkaline Phosphatase and Risk of Incident Cardiovascular Disease: Interrelationship with High Sensitivity C-Reactive Protein
por: Kunutsor, Setor K., et al.
Publicado: (2015)

Compositional Features of HDL Particles Interact with Albuminuria to Modulate Cardiovascular Disease Risk
por: Corsetti, James P., et al.
Publicado: (2019)

Cardiovascular disease in patients with non-alcoholic fatty liver disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

An analysis of Cyclin D1, Cytokeratin 5/6 and Cytokeratin 8/18 expression in breast papillomas and papillary carcinomas
por: Wang, Yu, et al.
Publicado: (2013)

Non-alcoholic fatty liver disease and cardiovascular risk
por: Patil, Rashmee, et al.
Publicado: (2017)

Low Serum Paraoxonase-1 Activity Associates with Incident Cardiovascular Disease Risk in Subjects with Concurrently High Levels of High-Density Lipoprotein Cholesterol and C-Reactive Protein
por: Corsetti, James P., et al.
Publicado: (2019)

Cytokeratin 5/6 and cytokeratin 8/18 expression in triple negative breast cancers: clinicopathologic significance in South-Asian population
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function
por: Gruppen, Eke G., et al.
Publicado: (2015)

Circulating trimethylamine‐N‐oxide is associated with all‐cause mortality in subjects with nonalcoholic fatty liver disease
por: Flores‐Guerrero, Jose L., et al.
Publicado: (2021)

Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort
por: van den Berg, Eline H., et al.
Publicado: (2017)

Non-alcoholic steatohepatitis in liver transplant recipients diagnosed by serum cytokeratin 18 and transient elastography: A prospective study
por: Alhinai, Alshaima, et al.
Publicado: (2021)

Immunohistochemistry of mammary Paget’s disease: Cytokeratin 7, GATA3, and HER2 are sensitive markers
por: Arain, Shoukat A., et al.
Publicado: (2020)

Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years
por: Ludwig, Ulla, et al.
Publicado: (2015)

Definition of Human Apolipoprotein A-I Epitopes Recognized by Autoantibodies Present in Patients with Cardiovascular Diseases
por: Teixeira, Priscila Camillo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ftr03k47g7o3cnbm0smaigc6gc